BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3034803)

  • 1. Presence of in vivo-activated T-cells expressing HLA-DR molecules and IL-2 receptors in peripheral blood of patients with nasopharyngeal carcinoma.
    Lakhdar M; Ellouz R; Kammoun H; Ben H'Tira S; Khedhiri N; Kastally R; Fridman WH
    Int J Cancer; 1987 Jun; 39(6):663-9. PubMed ID: 3034803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective homing of phenotypically lytic cells within nasopharyngeal carcinoma biopsies: numerous CD8- and CD16-positive cells in the tumor.
    Lakhdar M; Ben Aribia MH; Maalej M; Ladgham A
    Int J Cancer; 1991 Apr; 48(1):57-61. PubMed ID: 1826899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte subsets in tumour of patients with undifferentiated nasopharyngeal carcinoma: presence of lymphocytes with the phenotype of activated T cells.
    Herait P; Ganem G; Lipinski M; Carlu C; Micheau C; Schwaab G; De-The G; Tursz T
    Br J Cancer; 1987 Feb; 55(2):135-9. PubMed ID: 3545275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of lymphocyte subpopulations to phytohemagglutinin, concanavalin A and pokeweed mitogen in patients with nasopharyngeal carcinoma.
    Hsu MM; Lin BL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Nov; 18(4):224-31. PubMed ID: 3878769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood lymphocytes resistant to Epstein-Barr virus immortalization manifest high natural killer (NK) type activity against NK-resistant target cells.
    Gosselin J; Menezes J; Mercier G; Lamoureux G; Oth D
    Viral Immunol; 1990; 3(1):55-65. PubMed ID: 2153385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
    Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T
    Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 2-microglobulin and HLA-DR expression in relation to the presence of Epstein-Barr virus in nasopharyngeal carcinomas.
    Kouvidou C; Rontogianni D; Tzardi M; Datseris G; Panayiotides I; Darivianaki K; Karidi E; Delides G; Kanavaros P
    Pathobiology; 1995; 63(6):320-7. PubMed ID: 8738471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma.
    Butsch Kovacic M; Martin M; Gao X; Fuksenko T; Chen CJ; Cheng YJ; Chen JY; Apple R; Hildesheim A; Carrington M
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2673-7. PubMed ID: 16284396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HLA-DR antigens in nasopharyngeal carcinoma: an immunohistological analysis of the tumour cells and infiltrating lymphocytes.
    Thomas JA; Iliescu V; Crawford DH; Ellouz R; Cammoun M; de-Thé G
    Int J Cancer; 1984 Jun; 33(6):813-9. PubMed ID: 6329970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression of HLA, Epstein-Barr virus nuclear antigen and the infiltration of T lymphocyte subsets in nasopharyngeal biopsy tissues].
    Chen X; Cai Y; Sun N
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(1):6-9. PubMed ID: 8031607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity.
    Yamada S; Ruscetti FW; Overton WR; Herberman RB; Birchenall-Sparks MC; Ortaldo JR
    J Leukoc Biol; 1987 Jun; 41(6):505-17. PubMed ID: 3110337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive expression of HLA class II antigens on EBV positive malignant cells from nasopharyngeal carcinoma: possible involvement in T cell infiltration.
    Busson P; Braham K; Clausse B; Tursz T
    Cancer Detect Prev; 1988; 12(1-6):363-8. PubMed ID: 2846171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patients.
    Fliss-Jaber L; Houissa-Kastally R; Bouzouita K; Khediri N; Khelifa R
    BMC Cancer; 2004 Sep; 4():68. PubMed ID: 15450122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus specific T-cell response in nasopharyngeal carcinoma patients.
    Moss DJ; Chan SH; Burrows SR; Chew TS; Kane RG; Staples JA; Kunaratnam N
    Int J Cancer; 1983 Sep; 32(3):301-5. PubMed ID: 6309678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High interferon titer and defective NK-cell activity in the circulation of nasopharyngeal carcinoma patients.
    Lakhdar M; Oueslati R; Ellouze R; Thameur H; Cammoun M; Khedhiri N; Kastally R
    Int J Cancer; 1989 Apr; 43(4):543-8. PubMed ID: 2539326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of non-major-histocompatibility-complex-restricted lytic CD8+ cells in the blood of nasopharyngeal carcinoma patients.
    Lakhdar M; Thameur H; Maalej M; Ben Ayed F; Ladgham A
    Cancer Immunol Immunother; 1993 Jul; 37(2):131-9. PubMed ID: 8391392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
    Takenoyama M; Yasumoto K; Harada M; Matsuzaki G; Ishida T; Sugimachi K; Nomoto K
    Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma.
    Levine PH; Connelly RR; Herberman RB; McCoy JL; Fabrizio PL
    IARC Sci Publ (1971); 1975; (11 Pt 2):225-35. PubMed ID: 191366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy.
    Li J; Zeng XH; Mo HY; Rolén U; Gao YF; Zhang XS; Chen QY; Zhang L; Zeng MS; Li MZ; Huang WL; Wang XN; Zeng YX; Masucci MG
    PLoS One; 2007 Nov; 2(11):e1122. PubMed ID: 17987110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.